New Diagnostic Term for Obesity
The new term is not meant merely to “re-brand” obesity, but to frame it as a chronic disease with distinct complications.
Read More
New Schedule Proposed for Diabetic Retinopathy Screening
This screening model may improve retinopathy detection in patients with T1DM and decrease costs.
Top Hospital Employers
Whether you’re looking to make a change in employment, or are just curious, we’ve compiled a list of top hospital employers.
Metformin Linked to Decreased Mortality in CKD, CHF, and Liver Disease
While the strength of evidence for this "protective" effect is low, observers support further comparative effectiveness research in these patient groups.
Adjuvant Metformin in Type 1 Diabetes
This study is the first retrospective, long-term analysis of metformin as adjuvant therapy to insulin in patients with T1DM.
Blood Pressure Paradox: Hypertension Associated with Survival in T2D and HF
Patients with comorbid T2D and heart failure may have a "distinct pathophysiology of the heart" say authors of a new study.
GLP-1 Agonists: Beneficial in Low-Risk Patients?
Do low-risk CVD patients with T2DM experience the same significantly lower all-cause and CV mortality seen in high-risk patients?
SGLT2 Inhibitors Improve HF, Survival in Clinical T2D Population
Findings from the REAL-CVD outcomes study reported at ACC.17 suggest class effect for cardioprotection.
Bone Mineral Density in 50+ Years of Diabetes
A small pilot study is the first to report on bone health in people with an at least 50-year history of type 1 diabetes.
Evaluate Cardiometabolic Risk in Youth
How well do waist-to-height ratios calculated using NHANES and WHO protocols indicate cardiometabolic risk in youth with diabetes?
Impact of High-dose Statin on Plaque Morphology
Statins are clinically proven to improve CV outcomes--a new study offers insight into the mechanisms at work on arterial plaque.
Top 8 Endocrinology Apps
Eight top apps for endocrinologists include decision support tools, printable patient handouts, calculators, and treatment guidelines.
Glycemic Control: CGM vs Self-Monitoring
The study also compared psychosocial variables, including treatment satisfaction, well-being, and fear of hypoglycemia, during CGM vs self-monitoring.
Intentional Eating: CV Health & Obesity
The American Heart Association released a statement about the impact meal timing and frequency has on cardiometabolic health and obesity.
Underuse of VKAs: How Physician, Patient Perceptions Shape Practice
A new analysis of qualitative studies points to poor communication on multiple levels.
Sexual Dysfunction in Diabetes
Asking about and treating sexual dysfunction may not only improve a patient’s quality of life, but also address serious health problems down the road.
Moderate Exercise Still Standard vs High-intensity Routine in Chronic HF
SMARTEX HF is first multicenter RCT to evaluate high intensity interval training in patients with HFrEF
Diabetic Dyslipidemia: Fenofibrate plus Statin
Further study is needed, but adding fenofibrate to statins may decrease cardiovascular disease events in certain patients with type 2 diabetes.
Patient Risk Factors for Carotid Revascularization
The Cardiovascular Health Study identifies patient factors that can be modified to stem risk for CEA.
UTI Risk by Type of SGLT2 Inhibitor
The risk of urinary tract infections (UTIs), but not necessarily genital infections, may vary by agent within the SGLT2 inhibitor class.
Dual Hormone Bionic Pancreas vs Standard Care
The device, initialized using only body mass, with no required data on usual insulin regimens, was compared to standard care with insulin pump and CGM.
LADA: Time to Update Diabetes Classification?
Is LADA a separate disease entity or does it lie on an autoimmune continuum as a slowly progressive form of T1DM?
Nut Consumption: Time for New Recommendations?
Past studies have linked nut consumption to decreased risk of CVD & all-cause mortality, but have not systematically evaluated less common causes of death.
Young-Onset Diabetes: Type 1 vs Type 2
USA & Australian studies suggest young-onset T2DM may have a more aggressive disease course than T1DM, but data on non-European populations is scarce.
Racial and Ethnic Disparities in Diabetes
Creating a better understanding of how race and ethnicity impact social determinants of health can improve culturally tailored diabetes interventions.
Cardiovascular Effect of an SGLT2i: Case Study
A 68-year-old man with long-standing hypertension, ischemic heart disease, obesity, T2DM, & rheumatoid arthritis was treated with an SGLT2 inhibitor.
PAH-related Hospitalizations: Trends, Outcomes 2001-2012
The first study using a national inpatient database finds PAH-related costs, comorbidities are increasing.
Fertility Therapies & Diabetes Risk in Offspring
Researchers linked several national registries & the Danish Infertility Cohort to find data on women with infertility problems between 1963 and 2011.
Impact of Social Networks on Diabetes & CVD Risk
An exploratory study examined the effects of social networks on lifestyle behaviors in those at risk of type 2 diabetes and cardiovascular disease.
SGLT2 Inhibitors: Two Glucose-Lowering Mechanisms?
Researchers investigated the possibility of an SGLT2 inhibitor having two distinct dual glucose-lowering mechanisms, depending on body weight changes.